Expertise in
14
conditions

Keith G. Oldroyd

246 Clayton Road, 
Clayton, VIC, AU 
Expertise in
14
conditions
246 Clayton Road, 
Clayton, VIC, AU 
OverviewLocationsClinical Research

Overview

Keith Oldroyd practices in Clayton, Australia. Mr. Oldroyd is highly rated in 14 conditions, according to our data. His top areas of expertise are Heart Attack, Coronary Heart Disease, Angina, Percutaneous Coronary Intervention (PCI), and Angioplasty.

His clinical research consists of co-authoring 244 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

246 Clayton Road, Clayton, VIC 3168, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) 3 Trial A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease
Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) 3 Trial A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease
Enrollment Status: Active_not_recruiting
Publish Date: March 28, 2025
Intervention Type: Procedure, Device
Study Phase: Not Applicable
Angina in Patients Without Obstructive Coronary Disease As Revealed by CT Coronary Angiography (Cor-CTCA): an Observational Cohort Study Involving Coronary Function Tests and a Nested Randomised Trial
Angina in Patients Without Obstructive Coronary Disease As Revealed by CT Coronary Angiography (Cor-CTCA): an Observational Cohort Study Involving Coronary Function Tests and a Nested Randomised Trial
Enrollment Status: Active_not_recruiting
Publish Date: October 29, 2024
Intervention Type: Diagnostic test
Study Phase: Not Applicable
CORonary MICrovascular Angina (CorMicA): a Randomised, Controlled, Pilot Trial
CORonary MICrovascular Angina (CorMicA): a Randomised, Controlled, Pilot Trial
Enrollment Status: Completed
Publish Date: October 29, 2024
Intervention Type: Diagnostic test
Study Phase: Not Applicable
Prospective, Multicenter, Single-Arm, Global IDE Study of the Shockwave Coronary Intravascular Lithotripsy (IVL) System With the Shockwave C2 Coronary IVL Catheter in Calcified Coronary Arteries
Prospective, Multicenter, Single-Arm, Global IDE Study of the Shockwave Coronary Intravascular Lithotripsy (IVL) System With the Shockwave C2 Coronary IVL Catheter in Calcified Coronary Arteries
Enrollment Status: Completed
Publish Date: May 19, 2023
Intervention Type: Device
Study Phase: Not Applicable
Glasgow Natural History Study Of Covered Coronary Interventions
Glasgow Natural History Study Of Covered Coronary Interventions
Enrollment Status: Completed
Publish Date: October 19, 2022
Intervention Type: Device
How Often Can Optimal Post Percutaneous Coronary Intervention (PCI) Fractional Flow Reserve (FFR) Results be Achieved? - a Randomised Controlled Trial of FFR Targeted PCI (the Target FFR Study)
How Often Can Optimal Post Percutaneous Coronary Intervention (PCI) Fractional Flow Reserve (FFR) Results be Achieved? - a Randomised Controlled Trial of FFR Targeted PCI (the Target FFR Study)
Enrollment Status: Completed
Publish Date: March 31, 2022
Intervention Type: Diagnostic test, Procedure
Study Phase: Not Applicable
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination With Filgrastim in Early Recovery Post-Myocardial Infarction
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination With Filgrastim in Early Recovery Post-Myocardial Infarction
Enrollment Status: Completed
Publish Date: May 27, 2021
Intervention Type: Drug
Study Phase: Phase 2
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Enrollment Status: Completed
Publish Date: May 14, 2021
Intervention Type: Device
Study Phase: Phase 3
RATATOUILLE Study (inteRnATional hAnd funcTiOn stUdy Following dIstaL radiaL accEss)
RATATOUILLE Study (inteRnATional hAnd funcTiOn stUdy Following dIstaL radiaL accEss)
Enrollment Status: Completed
Publish Date: March 09, 2021
CONventional Antegrade vs Sub-Intimal Synergy sTENTing in Chronic Total Occlusions
CONventional Antegrade vs Sub-Intimal Synergy sTENTing in Chronic Total Occlusions
Enrollment Status: Unknown
Publish Date: May 18, 2017
Intervention Type: Device
A Randomised Controlled Trial in Stable Intermediate Coronary Lesions and Grey-zone FFR Values With Evaluation of the Diagnostic Utility of Invasive Coronary Physiological Indices and Quantitative Perfusion MRI. The GzFFR Study
A Randomised Controlled Trial in Stable Intermediate Coronary Lesions and Grey-zone FFR Values With Evaluation of the Diagnostic Utility of Invasive Coronary Physiological Indices and Quantitative Perfusion MRI. The GzFFR Study
Enrollment Status: Completed
Publish Date: March 03, 2017
Intervention Type: Procedure, Drug
Study Phase: Not Applicable
View 10 Less Clinical Trials

244 Total Publications

Biodegradable-polymer versus durable-polymer drug-eluting stents in left main percutaneous coronary intervention: final results of the randomised IDEAL-LM trial.
Biodegradable-polymer versus durable-polymer drug-eluting stents in left main percutaneous coronary intervention: final results of the randomised IDEAL-LM trial.
Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Published: June 04, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Oldroyd's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 12 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile